相关实验视频
Updated: Jul 3, 2025

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
急性严重性结肠炎的治疗:未回答的问题和最新的见解
Pauline Rivière1, Christopher Li Wai Suen2, María Chaparro3
1CHU de Bordeaux, Centre Medico-Chirurgical Magellan, Hôpital Haut-Lévêque, Gastroenterology Department, Université de Bordeaux, INSERM CIC 1401, Bordeaux, France.
急性严重性结肠炎 (ASUC) 是一种严重的发作,影响25%的患者,并带有并发症和死亡的风险. 本综述涵盖了包括JAK抑制剂在内的当前和新兴疗法,以改善ASUC管理.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 微生物组研究 微生物组研究
背景情况:
- 急性严重性结肠炎 (ASUC) 呈现全身炎症和血性腹,影响25%的性结肠炎患者.
- ASUC 发作带有严重的并发症,切除术和死亡风险.
- 目前尚不清楚ASUC的发病原因,并怀疑与受损的宿主微生物群相互作用有关.
研究的目的:
- 审查目前的知识和ASUC管理的最新进展.
- 讨论ASUC的第一线,第二线和潜在的第三线医学疗法.
- 探索ASUC的外科治疗选择和新兴的治疗策略.
主要方法:
- 关于ASUC病原和治疗的最新研究的文献综述.
- 分析当前和正在研究的疗法,包括肠道营养,类固醇和JAK抑制剂.
- 讨论治疗失败和个性化医疗方法的预测标记.
主要成果:
- 肠道营养与静脉注射类固醇相结合,显示出ASUC管理的前景.
- 早期预测治疗失败的第一线和第二线疗法是一个活跃的研究领域.
- 简氏激酶 (JAK) 抑制剂正在成为ASUC.ASUC的潜在第三线疗法.
结论:
- 需要进一步的研究来阐明ASUC的致病性和优化治疗策略.
- 针对ASUC,还需要开发使用多组学工具的个性化治疗框架.
- 更好的理解和治疗方法对于减少ASUC相关的发病率和死亡率至关重要.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...

